Cardio Diagnostics Holdings, Inc. (CDIO) 是一家上市公司 属于 医疗保健 板块，经营于 生物科技 行业. 公司总部位于 Chicago, IL, 美国. 现任CEO为 Meeshanthini V. Dogan.
CDIO 拥有 IPO日期为 2022-01-14, 13 名全职员工, 在 NASDAQ Capital Marke, 市值为 $3.56M.
Cardio Diagnostics Holdings, Inc. develops and commercializes epigenetics-based clinical tests for cardiovascular disease. It offers Epi+Gen CHD, a three-year symptomatic coronary heart disease risk assessment test. Cardio Diagnostics Holdings, Inc. was founded in 2017 and is based in Chicago, Illinois.
